Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01131611 · ClinicalTrials.gov registry record · Phase 1

Cognitive-Behavioral Physical Therapy

A Phase 1 study, sponsored by Vanderbilt University.

Completed
Registry status
Phase 1
Development phase
86
Enrollment target

NCT01131611: Completed Phase 1 study, sponsored by Vanderbilt University.

NCT01131611 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 86 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (43% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01131611, a Phase 1 study, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
Phase 1
Development phase
86 participants
Enrollment target

Study Summary

The overall objective of this application is to conduct a two-group randomized controlled trial (RCT) to gather preliminary evidence on the efficacy of a brief cognitive-behavioral based PT (CBPT) intervention in patients at-risk for poor outcomes following lumbar spine surgery for degenerative conditions. Our central hypothesis is that incorporating cognitive and behavioral strategies into postoperative standard of care PT will improve surgical outcomes, through reductions in fear of movement and pain catastrophizing. We have established the feasibility of training therapists in the CBPT intervention, recruiting and retaining patients, and the procedures for data collection and study management. The long-term goal is to broaden the availability of well-accepted and effective CBT strategies by expanding the implementation from traditional providers, psychologists, to a group of providers, physical therapists, who routinely interact with musculoskeletal pain populations.

Primary Outcome

The ODI measures disability

Interventions

  • BEHAVIORAL CBPT
  • OTHER Control-Attention

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2012-02
Est. Completion 2014-04
Phase Phase 1
Vanderbilt University

430 total trials

What the finished NCT01131611 record still lists

NCT01131611 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (43% higher).

The record links to 0 conditions, and to 2 interventions - of which CBPT is the first listed.

NCT01131611 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01131611 about?

NCT01131611 is a clinical study titled "Cognitive-Behavioral Physical Therapy". The overall objective of this application is to conduct a two-group randomized controlled trial (RCT) to gather preliminary evidence on the efficacy of a brief cognitive-behavioral based PT (CBPT) intervention in patients at-risk for poor outcomes following lumbar spine surgery for degenerative cond...

What is the current status of trial NCT01131611?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 86 participants. The study started on 2012-02. Estimated completion is 2014-04.

What interventions are being tested in trial NCT01131611?

The interventions under investigation include: CBPT (BEHAVIORAL), Control-Attention (OTHER).

Who is sponsoring clinical trial NCT01131611?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01131611's enrollment target sits among peer trials

86 652nd of 2000 higher than 1,345 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01639508 · 86 participants · Phase 2

    Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

  • NCT03519269 · 86 participants · NA

    Navio Robotic Versus Conventional Total Knee Arthroplasty

  • NCT04132999 · 86 participants · NA

    PAP for Children With DS and OSAS

  • NCT04545957 · 86 participants · NA

    Jump: MR Simulation For Radiation Therapy Master Protocol

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01131611, the US trial registry maintained by the National Library of Medicine. NCT01131611 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.